Nano-X Imaging Ltd. (NNOX)
NASDAQ: NNOX · Real-Time Price · USD
3.690
-0.010 (-0.27%)
At close: Oct 1, 2025, 4:00 PM EDT
3.690
0.00 (-0.01%)
After-hours: Oct 1, 2025, 5:57 PM EDT
Nano-X Imaging Market Cap
Nano-X Imaging has a market cap or net worth of $235.94 million as of October 1, 2025. Its market cap has decreased by -36.18% in one year.
Market Cap
235.94M
Enterprise Value
191.94M
1-Year Change
-36.18%
Ranking
Category
Stock Price
$3.69
Market Cap Chart
Since the IPO on August 21, 2020, Nano-X Imaging's market cap has decreased from $746.15M to $235.94M, a decrease of -68.38%. That is a compound annual growth rate of -20.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 30, 2025 | 236.58M | -43.85% |
| Dec 31, 2024 | 421.36M | 14.58% |
| Dec 29, 2023 | 367.76M | -4.66% |
| Dec 30, 2022 | 385.74M | -48.67% |
| Dec 31, 2021 | 751.50M | -64.45% |
| Dec 31, 2020 | 2.11B | 183.29% |
| Aug 21, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 731.31B |
| Johnson & Johnson | 443.71B |
| AbbVie | 423.88B |
| UnitedHealth Group | 312.10B |
| Novartis AG | 243.07B |
| Novo Nordisk | 240.58B |
| AstraZeneca | 233.08B |
| Abbott Laboratories | 226.63B |